Literature DB >> 24919763

Rapid skeletal turnover in a radiographic mimic of osteopetrosis.

Michael P Whyte1, Katherine L Madson, Steven Mumm, William H McAlister, Deborah V Novack, Jo C Blair, Timothy R Helliwell, Marina Stolina, Laurence J Abernethy, Nicholas J Shaw.   

Abstract

Among the high bone mass disorders, the osteopetroses reflect osteoclast failure that prevents skeletal resorption and turnover, leading to reduced bone growth and modeling and characteristic histopathological and radiographic findings. We report an 11-year-old boy with a new syndrome that radiographically mimics osteopetrosis (OPT), but features rapid skeletal turnover. He presented at age 21 months with a parasellar, osteoclast-rich giant cell granuloma. Radiographs showed a dense skull, generalized osteosclerosis and cortical thickening, medullary cavity narrowing, and diminished modeling of tubular bones. His serum alkaline phosphatase was >5000 IU/L (normal <850 IU/L). After partial resection, the granuloma re-grew but then regressed and stabilized during 3 years of uncomplicated pamidronate treatment. His hyperphosphatasemia transiently diminished, but all bone turnover markers, especially those of apposition, remained elevated. Two years after pamidronate therapy stopped, bone mineral density (BMD) Z-scores reached +9.1 and +5.8 in the lumbar spine and hip, respectively, and iliac crest histopathology confirmed rapid bone remodeling. Serum multiplex biomarker profiling was striking for low sclerostin. Mutation analysis was negative for activation of lipoprotein receptor-related protein 4 (LRP4), LRP5, or TGFβ1, and for defective sclerostin (SOST), osteoprotegerin (OPG), RANKL, RANK, SQSTM1, or sFRP1. Microarray showed no notable copy number variation. Studies of his nonconsanguineous parents were unremarkable. The etiology and pathogenesis of this unique syndrome are unknown.
© 2014 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BIOMARKER PROFILING; GIANT CELL GRANULOMA; OSTEOSCLEROSIS; SCLEROSTIN

Mesh:

Substances:

Year:  2014        PMID: 24919763      PMCID: PMC4391634          DOI: 10.1002/jbmr.2289

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  47 in total

1.  Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis; Ioannis Litsas; Zoe Efstathiadou; Marina Kita; Georgios Arsos; Efstratios Moralidis; Athanasios Papatheodorou; Evangelos Terpos
Journal:  J Bone Miner Metab       Date:  2010-06-09       Impact factor: 2.626

2.  Giant-cell reparative granuloma, traumatic bone cyst, and fibrous (fibro-oseous) dysplasia of the jawbones.

Authors:  H L JAFFE
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1953-01

3.  High-bone-mass disease and LRP5.

Authors:  Michael P Whyte; William H Reinus; Steven Mumm
Journal:  N Engl J Med       Date:  2004-05-13       Impact factor: 91.245

Review 4.  Searching for gene defects that cause high bone mass.

Authors:  M P Whyte
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

5.  Giant cell tumor occurring in familial Paget's disease of bone: report of clinical characteristics and linkage analysis of a large pedigree.

Authors:  Fernando Gianfrancesco; Domenico Rendina; Daniela Merlotti; Teresa Esposito; Mustapha Amyere; Daniela Formicola; Riccardo Muscariello; Gianpaolo De Filippo; Pasquale Strazzullo; Ranuccio Nuti; Mikka Vikkula; Luigi Gennari
Journal:  J Bone Miner Res       Date:  2013-02       Impact factor: 6.741

6.  Creatine kinase brain isoenzyme (BB-CK) presence in serum distinguishes osteopetroses among the sclerosing bone disorders.

Authors:  M P Whyte; A Chines; D P Silva; Y Landt; J H Ladenson
Journal:  J Bone Miner Res       Date:  1996-10       Impact factor: 6.741

7.  Giant cell reparative granuloma of Paget's disease of bone: a unique clinical entity.

Authors:  K S Upchurch; L S Simon; A L Schiller; D I Rosenthal; E W Campion; S M Krane
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

8.  Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease.

Authors:  A Kinoshita; T Saito; H Tomita; Y Makita; K Yoshida; M Ghadami; K Yamada; S Kondo; S Ikegawa; G Nishimura; Y Fukushima; T Nakagomi; H Saito; T Sugimoto; M Kamegaya; K Hisa; J C Murray; N Taniguchi; N Niikawa; K Yoshiura
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

9.  Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.

Authors:  Nancy Laurin; Jacques P Brown; Jean Morissette; Vincent Raymond
Journal:  Am J Hum Genet       Date:  2002-04-30       Impact factor: 11.025

10.  Giant cell bone lesions in the craniofacial region: a diagnostic and therapeutic challenge.

Authors:  Bruno Barros Pinto Borges; Marco Aurélio Fornazieri; Ana Paula Correia de Araújo Bezerra; Leandro Aurélio Liporoni Martins; Fábio de Rezende Pinna; Richard Louis Voegels
Journal:  Int Forum Allergy Rhinol       Date:  2012-05-07       Impact factor: 3.858

View more
  6 in total

1.  Neonatal High Bone Mass With First Mutation of the NF-κB Complex: Heterozygous De Novo Missense (p.Asp512Ser) RELA (Rela/p65).

Authors:  Anja L Frederiksen; Martin J Larsen; Klaus Brusgaard; Deborah V Novack; Peter Juel Thiis Knudsen; Henrik Daa Schrøder; Weimin Qiu; Christina Eckhardt; William H McAlister; Moustapha Kassem; Steven Mumm; Morten Frost; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2015-08-06       Impact factor: 6.741

2.  Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation.

Authors:  Steven Mumm; Gary S Gottesman; Deborah Wenkert; Philippe M Campeau; Angela Nenninger; Margaret Huskey; Vinieth N Bijanki; Deborah J Veis; Aileen M Barnes; Joan C Marini; Marina Stolina; Fan Zhang; William H McAlister; Michael P Whyte
Journal:  Bone       Date:  2019-08-28       Impact factor: 4.398

3.  Gnathodiaphyseal dysplasia: Severe atypical presentation with novel heterozygous mutation of the anoctamin gene (ANO5).

Authors:  Ghada A Otaify; Michael P Whyte; Gary S Gottesman; William H McAlister; J Eric Gordon; Abby Hollander; Marisa V Andrews; Samir K El-Mofty; Wei-Shen Chen; Deborah V Veis; Marina Stolina; Albert S Woo; Panagiotis Katsonis; Olivier Lichtarge; Fan Zhang; Marwan Shinawi
Journal:  Bone       Date:  2017-11-21       Impact factor: 4.398

4.  Idiopathic Acquired Osteosclerosis in a Middle-Aged Woman With Systemic Lupus Erythematosus.

Authors:  Núria Guañabens; Steven Mumm; Laia Gifre; Silvia Ruiz-Gaspà; Jennifer L Demertzis; Marina Stolina; Deborah V Novack; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2016-05-09       Impact factor: 6.741

5.  Unique Variant of NOD2 Pediatric Granulomatous Arthritis With Severe 1,25-Dihydroxyvitamin D-Mediated Hypercalcemia and Generalized Osteosclerosis.

Authors:  Michael P Whyte; Emilina Lim; William H McAlister; Gary S Gottesman; Lien Trinh; Deborah J Veis; Vinieth N Bijanki; Matthew G Boden; Angela Nenninger; Steven Mumm; David Buchbinder
Journal:  J Bone Miner Res       Date:  2018-07-30       Impact factor: 6.741

6.  Juvenile Paget's Disease From Heterozygous Mutation of SP7 Encoding Osterix (Specificity Protein 7, Transcription Factor SP7).

Authors:  Michael P Whyte; Philippe M Campeau; William H McAlister; G David Roodman; Nori Kurihara; Angela Nenninger; Shenghui Duan; Gary S Gottesman; Vinieth N Bijanki; Homer Sedighi; Deborah J Veis; Steven Mumm
Journal:  Bone       Date:  2020-04-13       Impact factor: 4.398

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.